Oncology Outpatient Daily Report: Tuesday, October 2 2018
Oncology Outpatient Daily Report: Tuesday, October 2 2018
Oncology Outpatient Daily Report: Tuesday, October 2 2018
DAILY REPORT
Consultant incharge:
dr. H. Rizal Sanif, SpoG (K), MARS
ONCOLOGY OUTPATIENT RECAPITULATION
No. Diagnosis ICD 10 New case Old case Procedure ICD 9
H A H A
Continue radiotherapy
Cervical ca std IV B (pulmon - - -
1 C53.9 - Consultation to 180.9
ary metastase)
radiotherapy
Ovarian ca std IC complete t - - -
2 C56.1 - Tumor marker evaluation 184.0
herapy
Endometrial ca std IIIC com
3 C54.1 - - - - Pap smear 182.0
plete therapy
Pap smear
Endometrial ca std IIIC com
4 C54.1 - - - - Consultation to interna 182.0
plete therapy + DM t.II
department
pro VC Laparotomy
NOP multiloculare with kati
Consultation to interna d
k bilateral+ Endometrial hyp
5 D27.9 - - - - epartment 220.0
erplasia DD/ Endometrial
Consultation to anesthesi
malignancy
department
Ovarian ca advanced stage c
6 omplete C561 - - - - CT Scan Abdomen Pelvic 184.0
therapy
Ovarian ca std IIIC + mild an Pro chemotherapy brexel-
7 C561 - - - - 184.0
emia + leukopenia carboplatin 2nd course
Cervical Ca std IB complete Pap smear evaluation 6 m
8 C53.9 - - - - 180.9
therapy onths later
ONCOLOGY PATIENT’S RECAPITULATION\
No. IDENTITY DIAGNOSIS ICD 10 PROCEDURE ICD 9 PHYSI Consultant
CIAN incharge
Continue
Cervical ca std IV B (
Mrs. IND/44/ radiotherapy
1 pulmonary metastas C53.9 180.9 AM RS
UA/P5A0 Consultation to
e)
radiotherapy
Mrs. ROS/46/
Ovarian ca std IC co Tumor marker
2 RA/P0A0 C56.1 184.0 IS RS
mplete therapy evaluation
Mrs. DAR/56/ Endometrial ca std II
3 C54.1 Pap smear 182.0 IS RS
RA/P2A1 IC complete therapy
Endometrial ca std II Pap smear
Mrs. BOI/R52
4 IC complete therapy C54.1 Consultation to 182.0 RS RS
/UA/P7A0
+ DM t.II interna department
NOP multiloculare pro VC Laparotomy
with katik bilateral+ Consultation to inte
Ms. WON/50
5 Endometrial hyperpl D27.9 rna department 220.0 RS RS
/UA/P0A0
asia DD/ Endometri Consultation to ane
al malignancy sthesi department
Ovarian ca advance
Ms. YUL/21/R CT Scan Abdomen P
6 d stage complete C561 184.0 IS RS
A/P0A0 elvic
therapy
Ovarian ca std IIIC + Pro chemotherapy
Mrs. SUN/56/
7 mild anemia + leuko C561 brexel-carboplatin 184.0 IS RS
RA/P6A0
penia 2nd course
Mrs. PAR/53/ Cervical Ca std IB Pap smear evaluati
1. Mrs. IND/44/UA/P5A0
S/ chemotherapy control
Patient come with diagnose cervical ca std IVB (pulmonary metastase). Patient has finished
chemotherapy pacli-carbo 6th series (30-8-18). PA result 1803/A/2018: non keratinizing squamous cell
carcinoma on vaginal biopsy.
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
Lab result (10-1-18)= AFP 1,71; CEA (result follow); CA125 25,95
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
A/ NOP multiloculare with katik bilateral+ Endometrial hyperplasia DD/ Endometrial malignancy
P/ pro VC Laparotomy
Consultation to interna department
Consultation to anesthesi department
6. Ms. YUL/21/RA/P0A0
S/ control tumor marker
Patient come with diagnose ovarian ca advanced stage complete therapy
h/ suboptimal debulking laparotomy (3-9-17) PA result 3794/A/2017= left ovary, infundibulo
pelvicum ligament, right fallopian tube, KGB, omentum + peritoneal fluid not found malignancy cells
h/ tumor removal surgery (Muara Enim, 2-4-17) with PA result 566/DH/2017= yolk sac ovarian tumor.
Tumor marker evaluation:
NO DATE AFP CEA CA 125
1 2-2-18 1,88 1,84 10,66
2 3-5-18 1,90 15,1
3 6-8-18 2,10 81,5
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
Lab result (1-10-18): Hb 9,9; Leu 4100; trombo 196000;
O/
Abdominal palpation: flat, supple, symmetric, tenderness (-), free fluid sign (-), mass (-)
Speculum examination: normal vaginal stump
Vaginal toucher: normal vaginal stump
Pap smear result (24-9-18)= no malignant cells were found on the preparation; degenerative cells cause
d by chemoradiation